Euro-Med Laboratories Philippines (PHS:EURO) Equity-to-Asset : 0.56 (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Euro-Med Laboratories Philippines Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Euro-Med Laboratories Philippines's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₱5,890 Mil. Euro-Med Laboratories Philippines's Total Assets for the quarter that ended in Mar. 2024 was ₱10,600 Mil. Therefore, Euro-Med Laboratories Philippines's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.56.

The historical rank and industry rank for Euro-Med Laboratories Philippines's Equity-to-Asset or its related term are showing as below:

PHS:EURO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52 Med: 0.56 Max: 0.6
Current: 0.56

During the past 13 years, the highest Equity to Asset Ratio of Euro-Med Laboratories Philippines was 0.60. The lowest was 0.52. And the median was 0.56.

PHS:EURO's Equity-to-Asset is ranked worse than
51.89% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs PHS:EURO: 0.56

Euro-Med Laboratories Philippines Equity-to-Asset Historical Data

The historical data trend for Euro-Med Laboratories Philippines's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euro-Med Laboratories Philippines Equity-to-Asset Chart

Euro-Med Laboratories Philippines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.53

0.54

0.58

0.57

0.54

Euro-Med Laboratories Philippines Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial															0.58	0.58	0.58	0.54	0.56

Competitive Comparison of Euro-Med Laboratories Philippines's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euro-Med Laboratories Philippines's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Euro-Med Laboratories Philippines's Equity-to-Asset falls into.

Euro-Med Laboratories Philippines Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Euro-Med Laboratories Philippines's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	5845.188	/	10763.918
	=	0.54

Euro-Med Laboratories Philippines's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	5889.721	/	10599.961
	=	0.56

Euro-Med Laboratories Philippines (PHS:EURO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Euro-Med Laboratories Philippines Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Euro-Med Laboratories Philippines's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Euro-Med Laboratories Philippines (PHS:EURO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euro-Med Laboratories Philippines Inc (PHS:EURO) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

San Marcelino Street, 1000 United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000

Website

http://www.euromedlab.net

Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small volume parenterals and other solutions. The company also manufactures sterile water for the injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. It operates through the following segments: The Manufacturing pharmaceutical segment involves the manufacturing of pharmaceutical products. The Health and other care Service segment operates a dialysis center. Development and operation of quick-service restaurant segment include operations of the quick-service restaurant, catering, food production and other related services.

Euro-Med Laboratories Philippines (PHS:EURO) Headlines

No Headlines